Minaei et al
Notably, a clinical study demonstrated that T2DM patients receiving insulin therapy experienced significantly higher rates of pancreatitis compared to those treated with GLP-1RAs, and notably, no pancreatitis cases have been reported in clinical trials of the novel GLP-1RA Cotadutide, indicating that a comprehensive risk assessment of GLP-1RAs for pancreatic cancer remains premature pending additional data on these novel medications [8]
Cannabis smoking and diabetes mellitus: results from meta-analysis with eight independent replication samples
Scheduled inspections and sanitization help sustain GMP compliance, protect product integrity, and minimize the risk of manufacturing errors or contamination in semaglutide powder production
We saved lives through the rapid vaccine development, and also not only the development, but getting shots in the arms, right
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial
